Literature DB >> 15900571

Influence of protein binding on acrolein turnover in vitro by oxazaphosphorines and liver microsomes.

Frank Baumann1, Renate Schmidt, Jens Teichert, Rainer Preiss.   

Abstract

For a correct determination of acrolein amounts generated in in vitro turnover experiments with oxazaphosphorines, it is necessary to characterize the interaction of acrolein with liver microsomal proteins. Acrolein, a highly reactive metabolite of oxazaphosphorines, readily forms covalent adducts with proteins by electrophilic attack on nucleophiles, such as the sulfhydryl group of cysteine, imidazole group of histidine, and amino group of lysine. The current investigations were mainly directed toward determination of the degree of acrolein-protein binding under conditions of in vitro experiments with liver microsome preparations. The acrolein concentration in protein dilution was determined by a fluorescence method. Moreover, the influence of sucrose and glycerine on the extent of acrolein-protein binding commonly used for the stabilization of microsomal preparations during storage was investigated. The current investigations show evidence that the chemical reaction of acrolein with liver microsomal proteins strictly follows first order kinetics. The main part of the formed acrolein in the in vitro attempts is available as bound part. Results of these investigations indicate that the calibration should be carried out with mixtures from liver microsome preparations and known amounts of acrolein under the same conditions as the in vitro experiments to record the entirely formed acrolein part (free and bound) in oxazaphosphorine turnover experiments. Glycerine is recommended as a preservative to store liver microsomes instead of sucrose because the latter reacts with acrolein. Copyright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15900571      PMCID: PMC6808015          DOI: 10.1002/jcla.20062

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  16 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

2.  High-performance liquid chromatographic determination of acrolein as a marker for cyclophosphamide bioactivation in human liver microsomes.

Authors:  F Bohnenstengel; M Eichelbaum; E Golbs; H K Kroemer
Journal:  J Chromatogr B Biomed Sci Appl       Date:  1997-04-25

3.  Protein-bound acrolein: potential markers for oxidative stress.

Authors:  K Uchida; M Kanematsu; K Sakai; T Matsuda; N Hattori; Y Mizuno; D Suzuki; T Miyata; N Noguchi; E Niki; T Osawa
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

4.  Fluorometric determination of acrolein and related compounds with m-aminophenol.

Authors:  R A Alarcon
Journal:  Anal Chem       Date:  1968-09       Impact factor: 6.986

5.  Thiolation of protein-bound carcinogenic aldehyde. An electrophilic acrolein-lysine adduct that covalently binds to thiols.

Authors:  Atsunori Furuhata; Mitsuhiro Nakamura; Toshihiko Osawa; Koji Uchida
Journal:  J Biol Chem       Date:  2002-05-24       Impact factor: 5.157

6.  Identification of the major human hepatic cytochrome P450 involved in activation and N-dechloroethylation of ifosfamide.

Authors:  D Walker; J P Flinois; S C Monkman; C Beloc; A V Boddy; S Cholerton; A K Daly; M J Lind; A D Pearson; P H Beaune
Journal:  Biochem Pharmacol       Date:  1994-03-29       Impact factor: 5.858

7.  Measurement of 4-hydroxylation of ifosfamide in human liver microsomes using the estimation of free and protein-bound acrolein and codetermination of keto- and carboxyifosfamide.

Authors:  Rainer Preiss; Renate Schmidt; Frank Baumann; Henning Hanschmann; Johann Hauss; Felix Geissler; Hartmut Pahlig; Bernd Ratzewiss
Journal:  J Cancer Res Clin Oncol       Date:  2002-06-11       Impact factor: 4.553

8.  Direct gas chromatographic determination of dechloroethylcyclophosphamide following microsomal incubation of cyclophosphamide.

Authors:  F Bohnenstengel; S Johnson; U Hofmann; M Eichelbaum; H K Kroemer
Journal:  J Chromatogr B Biomed Appl       Date:  1995-10-20

9.  Studies on the mechanism of denaturation of cytochrome P-450 by cyclophosphamide and its metabolites.

Authors:  H L Gurtoo; A J Marinello; R F Struck; B Paul; R P Dahms
Journal:  J Biol Chem       Date:  1981-11-25       Impact factor: 5.157

10.  Platinum anticancer drugs modulate P-450 mRNA levels and differentially alter hepatic drug and steroid hormone metabolism in male and female rats.

Authors:  G A LeBlanc; S S Sundseth; G F Weber; D J Waxman
Journal:  Cancer Res       Date:  1992-02-01       Impact factor: 12.701

View more
  1 in total

1.  Acrolein: unwanted side product or contribution to antiangiogenic properties of metronomic cyclophosphamide therapy?

Authors:  M Günther; E Wagner; M Ogris
Journal:  J Cell Mol Med       Date:  2008-02-04       Impact factor: 5.310

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.